CLINICAL STUDY OF UMBILICAL CORD MESENCHYMAL STEM CELLS AS THERAPEUTIC STRATEGY FOR COVID-19: A SYSTEMATIC REVIEW

Medicine and Dentistry

• Clinical Study 100%
• Mesenchymal Stem Cell 100%
• Umbilical Cord 100%
• Systematic Review 100%
• Umbilical Cord-Derived Mesenchymal Stem Cell 100%
• COVID-19 100%
• Mortality Rate 28%
• Cytokine Storm 28%
• Side Effect 14%
• CD8 Antigen 14%
• Adjuvant Therapy 14%
• Interleukin 6 14%
• Clinical Trial 14%
• Serositis 14%
• Receptor 14%
• Interleukin 10 14%
• D-Dimer 14%
• Disease 14%
• CD3 Antigen 14%

Keyphrases

• Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs) 100%
• Therapeutic Strategies 100%
• COVID-19 100%
• Mortality Rate 25%
• Cytokine Storm 25%
• Pneumonia 12%
• Inflammation Response 12%
• D-dimer 12%
• Reaction Rate 12%
• Google Scholar 12%
• Mesenchymal Stem Cells 12%
• CD4+ 12%
• CD3+ 12%
• Adjuvant Therapy 12%
• Therapeutic Treatment 12%
• Interleukin-6 12%
• Clinical Trials 12%
• CD8+ 12%
• PubMed 12%
• Interleukin-10 12%
• Mesenchymal Stem Cell Therapy 12%
• Route of Administration 12%
• PRISMA Statement 12%
• Immunomodulatory Effect 12%
• Minimum Side Effects 12%
• COVID-19 Patients 12%
• ACE2 Receptor 12%
• Reported Deaths 12%
• Pandemic Coronavirus 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Study 100%
• Coronavirinae 100%
• Diseases 100%
• Mortality Rate 33%
• Cytokine Storm 33%
• Receptor 16%
• Side Effect 16%
• Inflammation 16%
• Interleukin 6 16%
• Clinical Trial 16%
• Interleukin 10 16%
• Route of Administration 16%
• D Dimer 16%
• CD8 Antigen 16%
• CD3 Antigen 16%